Skip to main content
Gland Pharma Limited (NSE:GLAND)
India flag India · Delayed Price · Currency is INR
1,822.20
-39.00 (-2.10%)
At close: Feb 27, 2026

Gland Pharma Revenue

Gland Pharma had revenue of 16.95B INR in the quarter ending December 31, 2025, with 22.49% growth. This brings the company's revenue in the last twelve months to 61.13B, up 6.70% year-over-year. In the fiscal year ending March 31, 2025, Gland Pharma had annual revenue of 56.17B, down -0.85%.

Revenue (ttm)
61.13B
Revenue Growth
+6.70%
P/S Ratio
4.91
Revenue / Employee
14.05M
Employees
4,351
Market Cap
300.22B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 202556.17B-482.18M-0.85%
Mar 31, 202456.65B20.40B56.29%
Mar 31, 202336.25B-7.76B-17.64%
Mar 31, 202244.01B9.38B27.08%
Mar 31, 202134.63B8.30B31.51%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Emcure Pharmaceuticals 88.50B
Ajanta Pharma 52.02B
Ipca Laboratories 95.06B
Wockhardt 31.74B
Piramal Pharma 88.71B
Eris Lifesciences 30.65B
NATCO Pharma 45.63B
Laurus Labs 67.22B
Revenue Rankings

Gland Pharma News

More News